For instance, curcumin or melatonin have been shown to inhibit NLRP3 inflammasome and TLR4/MyD88/NF-κB signaling pathway respectively, reducing abdominal pain as well as acting like immune checkpoints in preclinical models of colitis [3,4,5]. Here, MYD88 is linked to colitis.